Vorinostat Unknown Status Phase 2 Trials for Essential Thrombocythemia (ET) / Polycythemia Vera (PV) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00866762A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia